
XPRIZE Healthspan Competition Advances with Focus on Holistic Therapeutics
Updated September 3, 2026
The XPRIZE Healthspan competition, which aims to develop therapeutics that can restore age-related declines in muscle, cognitive, and immune functions, has reached a critical stage with twenty teams moving forward. Ten teams have received Milestone 2 awards of $1 million each, indicating significant progress in the quest for effective healthspan interventions. Jamie Justice, the Executive Director of XPRIZE Healthspan, emphasizes the importance of a comprehensive evaluation of these therapeutics.
Share this story
Why it matters
- ✓The competition highlights the growing focus on developing therapeutics that address multiple aspects of aging, which could lead to more effective health optimization strategies.
- ✓Successful interventions could significantly enhance quality of life for older adults, making longevity more achievable for the general population.
- ✓Insights from the judging process may inform future research and development in the field of longevity and health optimization.
XPRIZE Healthspan Competition Advances with Focus on Holistic Therapeutics
The XPRIZE Healthspan competition is making significant strides in its mission to develop therapeutics that can combat age-related declines in muscle, cognitive, and immune functions. With a total investment of $101 million over seven years, this initiative is designed to foster innovation in the field of longevity and health optimization. As of now, twenty teams have reached the final stage of the competition, with ten of those teams securing $1 million Milestone 2 awards for their promising developments.
Overview of the XPRIZE Healthspan Competition
Launched to stimulate breakthroughs in healthspan enhancement, the XPRIZE Healthspan competition is focused on finding effective solutions to restore lost functions associated with aging. The competition has attracted a diverse array of teams, each working on unique approaches to tackle the multifaceted challenges of aging. The emphasis is on holistic therapeutics that can address not just one, but multiple aspects of age-related decline.
Jamie Justice, the Executive Director of XPRIZE Healthspan, has been instrumental in guiding the competition and evaluating the submissions. According to Justice, the judging process involves a comprehensive assessment of each team's approach, ensuring that the solutions are not only innovative but also practical and scalable. This holistic view is crucial, as it reflects the complexity of aging and the need for multifaceted interventions.
Importance of Holistic Evaluation
The phrase “judges are looking at the whole picture” underscores the competition's commitment to evaluating therapeutics in a comprehensive manner. This approach is essential for several reasons:
-
Complexity of Aging: Aging is not a linear process; it affects various bodily systems simultaneously. A therapeutic that addresses only one aspect may not be sufficient for overall health improvement.
-
Scalability: For a therapeutic to be widely adopted, it must be scalable and feasible for large populations. The judges are focused on solutions that can be implemented in real-world settings, which is critical for making a significant impact on public health.
-
Regulatory Navigation: As teams develop their therapeutics, they must also consider regulatory pathways. A holistic evaluation includes understanding how these interventions can be integrated into existing healthcare frameworks.
Progress and Milestones
With ten teams already awarded Milestone 2 funding, the competition is progressing rapidly. These awards are not just financial incentives; they also serve as validation of the teams' approaches and methodologies. The funding allows teams to further refine their projects and move closer to clinical application.
The competition is set to continue until 2026, with the ultimate goal of identifying therapeutics that can significantly extend healthspan—the period of life spent in good health. This is particularly relevant as the global population ages, and there is an increasing demand for effective interventions that can improve quality of life for older adults.
Implications for Longevity Enthusiasts
For those interested in longevity and health optimization, the developments emerging from the XPRIZE Healthspan competition are promising. The focus on holistic therapeutics suggests a shift towards more integrated approaches in health optimization strategies. As these innovations progress, they may lead to new options for enhancing healthspan, which could ultimately benefit a wide range of individuals seeking to improve their quality of life as they age.
Moreover, the insights gained from the judging process and the experiences of the competing teams could inform future research and development in the field. As the competition unfolds, it will be crucial for longevity enthusiasts to stay informed about the advancements and breakthroughs that arise from this initiative.
Conclusion
The XPRIZE Healthspan competition represents a significant effort to address the challenges of aging through innovative therapeutics. With a focus on holistic evaluation and practical applications, the competition is poised to contribute valuable insights and solutions to the field of longevity. As we look towards the future, the outcomes of this competition could pave the way for new strategies in health optimization and longevity, ultimately enhancing the well-being of individuals as they age.
Sources
- ‘Judges are looking at the whole picture’ — Longevity Technology
Comments
Log in with
Loading comments…
More in Biotech

Kailera Therapeutics Reports Q2 2026 Results and Obesity Trial Updates
Kailera Therapeutics has announced its financial results for the second quarter of 2026, along with…
1h ago

Function and NYU Grossman Collaborate on AI for Early Disease Detection
Function has partnered with NYU Grossman School of Medicine to initiate a multi-year research…
1h ago

Viome Acquires Circulate Health: A New Era for Blood Filtering in Wellness
Viome has acquired Circulate Health, combining precision diagnostics with therapeutic plasma…
1h ago

Immorta Bio Explores AI's Role in Longevity Research
Immorta Bio has released a new blueprint suggesting that the quest for longevity may not hinge on…
1h ago